Tvardi Therapeutics, Inc.
TVRD
$28.34
$1.706.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 143.50% | 24.62% | -65.99% | ||
| Total Depreciation and Amortization | -4.17% | 0.00% | -4.17% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -318.68% | 166.70% | -1.05% | ||
| Change in Net Operating Assets | 155.36% | -163.34% | 7,698.18% | ||
| Cash from Operations | 23.68% | -59.09% | 35.26% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 12.25% | -- | -- | ||
| Cash from Investing | 12.25% | -- | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 13,933.33% | -- | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 1,607.22% | -24.59% | -- | ||
| Cash from Financing | 1,636.31% | -105.94% | -100.00% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 145.65% | -190.98% | 35.18% | ||